Lifecore Biomedical, Inc. (LFCR)
6.38
-0.02
(-0.31%)
USD |
NASDAQ |
Nov 06, 10:20
Lifecore Biomedical Enterprise Value : 432.87M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 432.87M |
| November 04, 2026 | 434.39M |
| November 03, 2026 | 433.63M |
| November 02, 2026 | 432.49M |
| October 30, 2026 | 432.87M |
| October 29, 2026 | 437.42M |
| October 28, 2026 | 437.04M |
| October 27, 2026 | 434.39M |
| October 26, 2026 | 434.39M |
| October 23, 2026 | 432.87M |
| October 22, 2026 | 431.73M |
| October 21, 2026 | 431.73M |
| October 20, 2026 | 431.73M |
| October 19, 2026 | 432.49M |
| October 16, 2026 | 432.11M |
| October 15, 2026 | 434.39M |
| October 14, 2026 | 433.63M |
| October 13, 2026 | 433.63M |
| October 12, 2026 | 434.39M |
| October 09, 2026 | 434.76M |
| October 08, 2026 | 434.01M |
| October 07, 2026 | 434.39M |
| October 06, 2026 | 434.76M |
| October 05, 2026 | 437.42M |
| October 02, 2026 | 438.18M |
| Date | Value |
|---|---|
| October 01, 2026 | 437.80M |
| September 30, 2026 | 439.69M |
| September 29, 2026 | 437.74M |
| September 28, 2026 | 435.11M |
| September 25, 2026 | 347.65M |
| September 24, 2026 | 351.04M |
| September 23, 2026 | 355.19M |
| September 22, 2026 | 358.77M |
| September 21, 2026 | 358.20M |
| September 18, 2026 | 357.45M |
| September 17, 2026 | 357.45M |
| September 16, 2026 | 346.14M |
| September 15, 2026 | 345.39M |
| September 14, 2026 | 349.53M |
| September 11, 2026 | 344.63M |
| September 10, 2026 | 343.50M |
| September 09, 2026 | 343.50M |
| September 08, 2026 | 351.80M |
| September 04, 2026 | 355.19M |
| September 03, 2026 | 353.30M |
| September 02, 2026 | 368.00M |
| September 01, 2026 | 354.81M |
| August 31, 2026 | 357.45M |
| August 28, 2026 | 360.47M |
| August 27, 2026 | 360.47M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 50.63B |
| Bio-Rad Laboratories, Inc. | 9.617B |
| Bruker Corp. | 10.48B |
| Azenta, Inc. | 1.362B |
| Danaher Corp. | 181.32B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -40.08M |
| Revenue (Quarterly) | 25.32M |
| Total Expenses (Quarterly) | 65.41M |
| EPS Diluted (Quarterly) | -1.084 |
| Gross Profit Margin (Quarterly) | 26.96% |
| Profit Margin (Quarterly) | -158.3% |
| Earnings Yield | -26.63% |